Activist 13D/13G Filings - Third Rock Ventures III L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-14
4:19 pm
Sale
13GVOYAGER THERAPEUTICS INC
VYGR
Third Rock Ventures III L.P.186,423
0.4%
-5,279,211decrease
(-96.59%)
View
2024-02-14
4:19 pm
Unchanged
13GFulcrum Therapeutics Inc.
FULC
Third Rock Ventures III L.P.2,343,154
3.8%
0
(Unchanged)
View
2024-02-14
4:15 pm
Unchanged
13GPLIANT THERAPEUTICS INC.
PLRX
Third Rock Ventures III L.P.2,132,867
3.6%
0
(Unchanged)
View
2023-02-14
4:08 pm
Sale
13GPLIANT THERAPEUTICS INC.
PLRX
Third Rock Ventures III L.P.2,132,867
4.4%
-3,706,293decrease
(-63.47%)
View
2023-02-14
4:07 pm
Sale
13GFulcrum Therapeutics Inc.
FULC
Third Rock Ventures III L.P.2,343,154
4.5%
-1,703,271decrease
(-42.09%)
View
2023-02-14
4:04 pm
Sale
13GNurix Therapeutics Inc.
NRIX
Third Rock Ventures III L.P.184,544
0.4%
-2,366,213decrease
(-92.77%)
View
2023-02-14
4:03 pm
Sale
13GRevolution Medicines Inc.
RVMD
Third Rock Ventures III L.P.1,939,692
2.2%
-3,713,598decrease
(-65.69%)
View
2023-02-14
4:02 pm
Sale
13GVOYAGER THERAPEUTICS INC
VYGR
Third Rock Ventures III L.P.5,465,634
14.2%
-3,953,663decrease
(-41.97%)
View
2022-02-14
5:06 pm
Sale
13GFulcrum Therapeutics Inc.
FULC
Third Rock Ventures III L.P.4,046,425
10%
-1,915,777decrease
(-32.13%)
View
2022-02-14
5:03 pm
Purchase
13GDecibel Therapeutics Inc.
DBTX
Third Rock Ventures III L.P.3,139,685
12.6%
3,139,685increase
(New Position)
View
2022-02-14
5:02 pm
Sale
13GRevolution Medicines Inc.
RVMD
Third Rock Ventures III L.P.5,653,290
7.7%
-3,295,779decrease
(-36.83%)
View
2022-02-14
4:57 pm
Sale
13GNurix Therapeutics Inc.
NRIX
Third Rock Ventures III L.P.2,550,757
5.7%
-2,871,792decrease
(-52.96%)
View
2022-02-14
4:52 pm
Sale
13GRelay Therapeutics Inc.
RLAY
Third Rock Ventures III L.P.362,619
0.3%
-10,188,496decrease
(-96.56%)
View
2021-02-16
4:17 pm
Purchase
13GPLIANT THERAPEUTICS INC.
PLRX
Third Rock Ventures III L.P.5,839,160
16.5%
5,839,160increase
(New Position)
View
2021-02-16
4:15 pm
Purchase
13GNurix Therapeutics Inc.
NRIX
Third Rock Ventures III L.P.5,422,549
14%
5,422,549increase
(New Position)
View
2021-02-16
4:12 pm
Purchase
13GRelay Therapeutics Inc.
RLAY
Third Rock Ventures III L.P.10,551,115
11.7%
10,551,115increase
(New Position)
View
2021-02-16
4:09 pm
Purchase
13GRevolution Medicines Inc.
RVMD
Third Rock Ventures III L.P.8,949,069
13.5%
8,949,069increase
(New Position)
View
2020-02-05
4:35 pm
Purchase
13GFulcrum Therapeutics Inc.
FULC
Third Rock Ventures III L.P.5,962,202
25.5%
5,962,202increase
(New Position)
View